SAN DIEGO--(BUSINESS WIRE)--Dear Shareholders:
On behalf of Batu Biologics, I am pleased to provide you with a year-end update recapping our progress in 2015 and overviewing our plans for 2016.
Main accomplishments in the past year include:
Publication of a peer-reviewed scientific manuscript together with key opinion leaders in the area of tumor immunotherapy demonstrating proof of concept efficacy in three animal models of cancer using our ValloVax product1.
On behalf of Batu Biologics, I am pleased to provide you with a year-end update recapping our progress in 2015 and overviewing our plans for 2016.
Main accomplishments in the past year include:
Publication of a peer-reviewed scientific manuscript together with key opinion leaders in the area of tumor immunotherapy demonstrating proof of concept efficacy in three animal models of cancer using our ValloVax product1.
